Skip links

Ruconest® [C1 esterase inhibitor (recombinant)]

Full Name Ruconest® [C1 esterase inhibitor (recombinant)]
Drug Ruconest
Manufacturer Pharming Group
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE)
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Ruconest Patient Enrollment Form
Phone Number 800-356-4252
Fax Number 847-631-6918
Product Website ruconest.com